Aesthetic Medical International announces restructuring
SHENZHEN, China, September 30, 2021 (GLOBE NEWSWIRE) – Aesthetic Medical International Holdings Group Limited (Nasdaq: AIH) (the “Company” or “AIH”), one of the leading providers of aesthetic medical services in China, announced today a preliminary plan of commercial and restructuring strategies. Given the time and effort required to assess the impact of such a plan on its financial results, the Company currently anticipates that the publication of its unaudited financial results for the three months and six months ended June 30, 2021 will be delayed. .
As a pioneer in the aesthetic medical services industry in China, the Company is committed to facilitating the orderly development of the market in a consistent manner. The Company intends to strategically reorient its development strategy from rapid national expansion to more focused, stable and sustainable growth in terms of revenues and profitability.
As such, the Company is considering a strategic restructuring, aimed at maximizing its resources with various new strategies, including, among others, the following:
1) More targeted market delineation – focus on the main regional markets, namely the Guangdong-Hong Kong-Macao Great Bay region and the Yangtze Delta region;
2) More regular development – adopt a cautious approach to acquisitions and strengthen organic growth by renovating existing flagship hospitals and investing in synergistic clinics; and
3) Healthier wallet – divest certain hospitals and clinics located in non-strategic markets or which do not meet the Company’s internal performance requirements.
The Company expects the envisaged restructuring plan to be an essential step in consolidating its leading position and its competitiveness in the market, with an improvement in its overall operational efficiency. The Company believes that the plan will allow it to improve its profitability and have a healthier balance sheet over the long term.
About Aesthetic Medical International Holdings Group Limited
AIH, known as “Peng’ai” in China, is one of the leading providers of aesthetic medical services in China. AIH operates through processing centers located in major cities in mainland China and is also present in Hong Kong and Singapore. Drawing on over 20 years of clinical experience, AIH provides one-stop aesthetic service offerings, including surgical aesthetic treatments, non-surgical aesthetic treatments, general medical services, and other aesthetic services. According to some third-party industry consultants, AIH was the third-largest private aesthetic medical service provider in China by revenue in 2018. For more information on the company, please visit: https: //ir.aihgroup .net/.
The aforementioned plan is currently at a preliminary stage of formulation, and there is currently no definitive timetable for the implementation of such a plan. There is no guarantee that such a plan will be implemented in a timely manner or that it will produce the expected benefits, or not at all, and shareholders and investors are cautioned not to place undue reliance on this press release. Press.
This press release contains “forward-looking statements”. These statements are made under the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by words such as “will”, “expect”, “anticipate” “,” Goals “,” the future “,” intention “,” plans “,” believes “,” estimates “,”. Statements that are not historical facts, including statements about the Company’s beliefs, plans and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. These and other risks and uncertainties relating to the business and financial condition of the Company are detailed from time to time in documents filed by the Company with the SEC, and could cause actual results to differ materially. of those contained in any forward-looking statement. These forward-looking statements are made only as of the date indicated, and the Company assumes no obligation to update or revise the information contained in the forward-looking statements, except as required by applicable law.
Investor Relations Contacts
For investor and media inquiries, please contact:
Aesthetic Medical International Holdings Group Limited
Email: [email protected]
DLK Advisory Limited
Phone. : +852 2857 7101
Email: [email protected]